This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting on Aug 12, 2026 to approve Q1 FY27 results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 1.8 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The company has informed BSE that its Board of Directors will meet on Wednesday, August 12, 2026, at the registered office in Jaipur to approve the IND-AS compliant standalone unaudited financial results along with the Limited Review Report for the quarter ended June 30, 2026. The trading window for dealing in the companys securities has been closed since July 1, 2026, and will reopen 48 hours after the results are declared on the stock exchange.
Routine procedural filing; no financial impact until Q1 results are announced on Aug 12, 2026.
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹10.76 Cr | ₹9.47 Cr | +13.6% |
| Operating profit | ₹0.31 Cr | ₹0.39 Cr | −19.4% |
| Profit after tax | ₹0.26 Cr | ₹0.32 Cr | −18.2% |
| EBITDA margin | 8.0% | 9.8% | −1.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.